Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro

OBJECTIVE: Dendritic cells (DCs) are administered as immunotherapeutic adjuvants after the completion of standard treatment in most settings. However, our Phase I trial indicated that one patient out of four, who received autologous tumor lysate-pulsed dendritic cell (TLDC) also received cisplatin c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Gynecol Oncol
Päätekijät: Dhandapani, Hemavathi, Seetharaman, Abirami, Jayakumar, Hascitha, Ganeshrajah, Selvaluxmy, Singh, Shirley Sunder, Thangarajan, Rajkumar, Ramanathan, Priya
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8192235/
https://ncbi.nlm.nih.gov/pubmed/33908712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e59
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia